Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 616 of 1,261
  1. US 9725419

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  2. US 9724411

    Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  3. US 9724415

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  4. US 9724414

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  5. US 9724417

    Nanocarriers with multi-photon response elements

    The Regents of the University of California · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  6. US 9724408

    Compositions and methods for activating stimulator of interferon gene-dependent signalling

    The Regents of the University of California · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  7. US 9724376

    Olive leaf powder

    The United States of America as Represented by the Secretary of the Department of Agriculture · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  8. US 9724374

    Capsule containing total flavonoids of desmodium styracifolium, method for preparing the same and use

    WUHAN CHEMLIGAND BIO-PHARMACEUTICAL CO., LTD. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  9. US 9724380

    Method and compositions for synchronizing time of insemination in gilts

    JBS United Animal Health II LLC · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  10. US 9724359

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  11. US 9724350

    N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer

    Agios Pharmaceuticals, Inc. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  12. US 9724345

    Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same

    Platform Brightworks Two, Ltd. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  13. US 9724344

    Enhanced delivery of drug compositions to treat life threatening infections

    The Board of Regents of the University of Texas System · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  14. US 9724302

    Method for formulating large diameter synthetic membrane vesicles

    Pacira Pharmaceuticals, Inc. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  15. US 9724262

    Methods of diagnosing and treating neonatal reversion to fetal consciousness

    The Regents of the University of California · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  16. US 9724409

    Treatment of inflammatory skin disease

    XBIOTECH INC. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  17. US 9725431

    Oligomer-tricyclic conjugates

    Nektar Therapeutics · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  18. US 9725698

    Trophoblast-derived mesenchymal stem cells (T-MSCs) produced from human embryonic stem cells, methods and uses thereof

    UNIVERSITY OF CONNECTICUT · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  19. US 9725470

    Substituted naphthyridines as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  20. US 9725448

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  21. US 9724387

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  22. US 9724367

    Injectable formulations for organ augmentation

    RegenMed (Cayman) LTD. · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  23. US 9724339

    Methods and drug products for treating alzheimer's disease

    Takeda Pharmaceutical Company Limited · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  24. US 9718811

    (S)-enantiomer of mepazine

    Ludwig-Maximilians-Universitat Munchen · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.